Barclays’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.72M | Sell |
15,700
-300
| -2% | -$61.5K | ﹤0.01% | 2173 |
|
|
2025
Q4 | $4.1M | Sell |
16,000
-22,500
| -58% | -$5.9M | ﹤0.01% | 2373 |
|
|
2025
Q3 | $10M | Buy |
38,500
+31,300
| +435% | +$8.23M | ﹤0.01% | 1660 |
|
|
2025
Q2 | $1.76M | Sell |
7,200
-1,039,400
| -99% | -$259M | ﹤0.01% | 2950 |
|
|
2025
Q1 | $277M | Buy |
1,046,600
+1,005,600
| +2,453% | +$272M | 0.08% | 184 |
|
|
2024
Q4 | $10.4M | Sell |
41,000
-10,900
| -21% | -$2.92M | ﹤0.01% | 1541 |
|
|
2024
Q3 | $16.4M | Buy |
+51,900
| New | +$18.5M | ﹤0.01% | 1165 |
|
|
2024
Q2 | – | Sell |
-5,500
| Closed | -$1.91M | – | 5060 |
|
|
2024
Q1 | $1.91M | Sell |
5,500
-102,700
| -95% | -$38.9M | ﹤0.01% | 2607 |
|
|
2023
Q4 | $49.5M | Buy |
108,200
+83,800
| +343% | +$41.3M | 0.02% | 671 |
|
|
2023
Q3 | $11.9M | Buy |
+24,400
| New | +$11.5M | 0.01% | 928 |
|
|
2023
Q2 | – | Sell |
-2,900
| Closed | -$1.41M | – | 4765 |
|
|
2023
Q1 | $1.41M | Buy |
2,900
+1,000
| +53% | +$494K | ﹤0.01% | 2475 |
|
|
2022
Q4 | $973K | Buy |
+1,900
| New | +$999K | ﹤0.01% | 2829 |
|
|
2022
Q1 | – | Sell |
-23,200
| Closed | -$10.8M | – | 5247 |
|
|
2021
Q4 | $10.8M | Buy |
+23,200
| New | +$10.3M | ﹤0.01% | 1232 |
|
|
2020
Q2 | – | Sell |
-13,100
| Closed | -$4.11M | – | 5847 |
|
|
2020
Q1 | $4.11M | Buy |
13,100
+6,000
| +85% | +$2.02M | ﹤0.01% | 1638 |
|
|
2019
Q4 | $2.6M | Sell |
7,100
-1,700
| -19% | -$539K | ﹤0.01% | 2726 |
|
|
2019
Q3 | $2.25M | Sell |
8,800
-3,400
| -28% | -$953K | ﹤0.01% | 2712 |
|
|
2019
Q2 | $3.24M | Buy |
12,200
+9,300
| +321% | +$2.36M | ﹤0.01% | 2344 |
|
|
2019
Q1 | $771K | Sell |
2,900
-14,600
| -83% | -$4.21M | ﹤0.01% | 3684 |
|
|
2018
Q4 | $5.01M | Buy |
17,500
+11,800
| +207% | +$3.74M | ﹤0.01% | 1603 |
|
|
2018
Q3 | $1.93M | Sell |
5,700
-18,100
| -76% | -$5.88M | ﹤0.01% | 2922 |
|
|
2018
Q2 | $7.08M | Buy |
23,800
+21,100
| +781% | +$6.18M | 0.01% | 1465 |
|
|
2018
Q1 | $726K | Sell |
2,700
-12,100
| -82% | -$3.28M | ﹤0.01% | 3569 |
|
|
2017
Q4 | $3.67M | Sell |
14,800
-13,100
| -47% | -$3.23M | ﹤0.01% | 1897 |
|
|
2017
Q3 | $6.8M | Buy |
27,900
+2,300
| +9% | +$564K | 0.01% | 1309 |
|
|
2017
Q2 | $6.16M | Sell |
25,600
-48,800
| -66% | -$11M | 0.01% | 1313 |
|
|
2017
Q1 | $15.3M | Sell |
74,400
-511,500
| -87% | -$106M | 0.02% | 666 |
|
|
2016
Q4 | $120M | Buy |
585,900
+330,700
| +130% | +$63.1M | 0.13% | 120 |
|
|
2016
Q3 | $45.1M | Buy |
255,200
+210,200
| +467% | +$36.5M | 0.05% | 277 |
|
|
2016
Q2 | $8.1M | Buy |
45,000
+24,400
| +118% | +$4.33M | 0.01% | 962 |
|
|
2016
Q1 | $3.75M | Sell |
20,600
-88,000
| -81% | -$15.3M | 0.01% | 1400 |
|
|
2015
Q4 | $19.3M | Buy |
108,600
+75,100
| +224% | +$13.2M | 0.02% | 578 |
|
|
2015
Q3 | $6M | Sell |
33,500
-257,900
| -89% | -$47.7M | 0.01% | 1243 |
|
|
2015
Q2 | $55.7M | Buy |
291,400
+274,500
| +1,624% | +$50.9M | 0.06% | 261 |
|
|
2015
Q1 | $3.01M | Sell |
16,900
-16,100
| -49% | -$2.55M | ﹤0.01% | 1957 |
|
|
2014
Q4 | $4.72M | Sell |
33,000
-19,800
| -38% | -$2.71M | ﹤0.01% | 1747 |
|
|
2014
Q3 | $6.86M | Buy |
52,800
+12,800
| +32% | +$1.63M | 0.01% | 1492 |
|
|
2014
Q2 | $5.08M | Sell |
40,000
-21,900
| -35% | -$2.59M | 0.01% | 1734 |
|
|
2014
Q1 | $6.93M | Buy |
61,900
+4,800
| +8% | +$500K | 0.01% | 1448 |
|
|
2013
Q4 | $5.88M | Sell |
57,100
-179,500
| -76% | -$17.6M | 0.01% | 1685 |
|
|
2013
Q3 | $22M | Sell |
236,600
-297,400
| -56% | -$27.3M | 0.03% | 617 |
|
|
2013
Q2 | $45.1M | Buy |
+534,000
| New | +$42.2M | 0.06% | 288 |
|
Other funds holding HUM
VCM
VPM
SC
Barclays's HUM Position: Q1 2026 in Review
Barclays increased its Humana (HUM) stake by 13% in Q1 2026, buying an estimated $9.43M and bringing the position to 399,577 shares worth $69.3M. The position accounts for 0.02% of the portfolio, ranked #623.
Barclays first reported a position in HUM in Q2 2013 and has held it in 52 quarters since. The position peaked at $163M in Q4 2023. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.
- Barclays held 399,577 shares of Humana worth $69.3M as of Q1 2026.
- Barclays bought 45,998 Humana shares in Q1 2026, an estimated $9.43M.
- Humana made up 0.02% of Barclays's portfolio in Q1 2026, its #623 holding.
- Barclays first reported a position in Humana in Q2 2013 and has held it in 52 quarters since.
- Barclays's Humana position peaked at $163M in Q4 2023.
- 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.